Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Lower Risk of Scarring Because the treatment is non-invasive, there is far less risk of scarring compared to traditional surgical methods
Commonly Reported Side Effects Mild injection site irritation or redness Headache or fatigue (usually transient in early dosing) Nausea (rare, typically with higher doses or fasted use) In human trials, AOD9604 demonstrated a strong safety profile with no significant adverse effects or changes in glucose, insulin, or organ size. Heffernan et al., Journal of Endocrinology No IGF-1 Elevation or Growth Risks Unlike hGH, AOD9604 does not stimulate systemic growth meaning: No risk of acromegaly or organ hypertrophy No increase in cancer risk tied to IGF-1 elevation No suppression of natural hormone production Not a Controlled Substance AOD9604 is not scheduled or classified as a controlled substance in the U.S
Q: Are B12 shots safe
less specific than DPD
Table 5: Folic Acid Medication Table The table below is not an exhaustive list of all folic acid products and therapeutic considerations
